Information

Selective osteoinduction can prevent hip joint replacement.

For several months now, the team of the Clinic of Orthopedics and Traumatology at VITA Hospital has been applying an innovative surgical method that largely prevents future hip joint replacement.

Selective osteoinduction is indicated for patients suffering from avascular necrosis of the femoral head and fractures of the femoral neck. These are, in fact, among the most common causes of early joint replacement.

In orthopedic practice, it has been shown that about 10% of hip replacement cases result from avascular necrosis and about 30% follow a femoral neck fracture. A femoral neck fracture is one of the most common fractures in patients over 65 years of age, leading to a prolonged recovery (3-6 months) and high mortality.

In cases of avascular necrosis, standard surgical methods only slow down the process of bone destruction.

Selective osteoinduction is a relatively new method that overcomes many of the drawbacks of other surgical methods and has a very high success rate. At VITA Hospital, the approach has been brought over from Italy, where it has the greatest experience with it (more than 1 year).

The selective osteoinduction method consists of 3 main steps:

1. Preparation of a biological product from the patient's peripheral blood
2. Placement of a special fenestrated implant
3. Injection of the biological product

Advantages of the method over previous surgical techniques:

• Early mobilization and weight-bearing of the joint (from the 2nd postoperative day);
• Minimally invasive approach (incision 3-4 cm);
• Reduced operating time (15-30 min.);
• Minimal blood loss (30-50 ml);
• Reduced overall surgical risks (infection, thrombosis, postoperative pain, etc.);
• Ability for the patient to self-care as early as the day after the surgery;
• Short hospital stay (1-2 days).